FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue World Journal of Clinical Oncology Année : 2018

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer

Thierry André

Résumé

To evaluate the efficacy and safety of the modified FOLFIRI3-aflibercept as second-line therapy in patients with metastatic colorectal cancer.

Domaines

Cancer

Dates et versions

hal-01914895 , version 1 (07-11-2018)

Identifiants

Citer

Candice Carola, François Ghiringhelli, Stefano Kim, Thierry André, Juliette Barlet, et al.. FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer. World Journal of Clinical Oncology, 2018, 9 (5), pp.110 - 118. ⟨10.5306/wjco.v9.i5.110⟩. ⟨hal-01914895⟩
74 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More